Literature DB >> 4346579

Comparison of corticotrophin and corticosteroid response to lysine vasopressin, insulin, and pyrogen in man.

J J Staub, J S Jenkins, J G Ratcliffe, J Landon.   

Abstract

Plasma corticotrophin (ACTH) and corticosteroid levels in response to lysine vasopressin (LVP), insulin hypoglycaemia, and pyrogen have been compared in seven subjects with normal pituitary adrenal function. Intramuscular vasopressin was a weak stimulus to corticotrophin release, peak values lying within the range 49 to 141 pg/ml. Insulin hypoglycaemia consistently caused a more noticeable increase, with peak levels between 114 and 364 pg/ml, while pyrogen was the most powerful, corticotrophin levels rising to between 209 and 1,725 pg/ml. Peak plasma corticosteroid levels showed less pronounced differences between the three tests, and correlated poorly with peak ACTH levels. Thus, relatively small acute changes in corticotrophin levels produce near-maximal adrenal stimulation. Under these conditions, plasma corticosteroid measurements do not accurately reflect circulating corticotrophin levels. These findings help to explain the physiological basis of several observations on the corticosteroid responses to these clinical test procedures.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4346579      PMCID: PMC1588039          DOI: 10.1136/bmj.1.5848.267

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  21 in total

1.  Threshold adrenocortical sensitivity in man and its possible application to corticotrophin bioassay.

Authors:  J Landon; V H James; M J Wharton; M Friedman
Journal:  Lancet       Date:  1967-09-30       Impact factor: 79.321

2.  Radioimmunoassay of ACTH in plasma.

Authors:  S A Berson; R S Yalow
Journal:  J Clin Invest       Date:  1968-12       Impact factor: 14.808

3.  A phenylalanine-lysine-vasopressin test of ACTH release.

Authors:  C A Strott; K Nakagawa; H Nankin; C A Nugent
Journal:  J Clin Endocrinol Metab       Date:  1967-03       Impact factor: 5.958

4.  Vasopressin-induced ACTH secretion in man.

Authors:  G Gwinup; T Steinberg; C G King; J Vernikos-Danellis
Journal:  J Clin Endocrinol Metab       Date:  1967-07       Impact factor: 5.958

5.  Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis.

Authors:  J R Daly; A B Myles; P A Bacon; C G Beardwell; O Savage
Journal:  Ann Rheum Dis       Date:  1967-01       Impact factor: 19.103

6.  Effects of a bacterial pyrogen on the pituitary-adrenal axis at various times in the 24 hours.

Authors:  K Takebe; C Setaishi; M Hirama; M Yamamoto; Y Horiuchi
Journal:  J Clin Endocrinol Metab       Date:  1966-04       Impact factor: 5.958

7.  Pituitary-adrenal function tests in patients with untreated pituitary tumours.

Authors:  J S Jenkins; W Else
Journal:  Lancet       Date:  1968-11-02       Impact factor: 79.321

8.  Plasma corticosteroid and growth hormone response to lysine-vasopressin in man.

Authors:  J Brostoff; V H James; J Landon
Journal:  J Clin Endocrinol Metab       Date:  1968-04       Impact factor: 5.958

9.  Test for pituitary function using vasopressin.

Authors:  G Gwinup
Journal:  Lancet       Date:  1965-09-18       Impact factor: 79.321

10.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects.

Authors:  F C Greenwood; J Landon; T C Stamp
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

View more
  8 in total

1.  Endocrine responses to insulin hypoglycaemia in the young calf.

Authors:  S R Bloom; A V Edwards; R N Hardy; K W Malinowska; M Silver
Journal:  J Physiol       Date:  1975-01       Impact factor: 5.182

Review 2.  Sex hormones, glucocorticoids and autoimmunity: facts and hypotheses.

Authors:  J A Da Silva
Journal:  Ann Rheum Dis       Date:  1995-01       Impact factor: 19.103

3.  Arginine vasopressin potentiates adrenocorticotropin release induced by ovine corticotropin-releasing factor.

Authors:  C R DeBold; W R Sheldon; G S DeCherney; R V Jackson; A N Alexander; W Vale; J Rivier; D N Orth
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

4.  Evidence for ACTH-unrelated mechanisms in the regulation of cortisol secretion in man.

Authors:  H L Fehm; R Holl; K Steiner; E Klein; K H Voigt
Journal:  Klin Wochenschr       Date:  1984-01-02

5.  Hypothalamic-pituitary functions in patients with idiopathic pituitary dwarfism. Further evidence for hypophysiotropic human deficiencies.

Authors:  O Nose; Y Iida; H Kai; T Harada; S Okada; H Yabuuchi; K Miyai
Journal:  Eur J Pediatr       Date:  1978-08-17       Impact factor: 3.183

6.  The plasma interleukin-6 and stress hormone responses to acute pyelonephritis.

Authors:  R A Donald; R R Bailey; D Hart; J H Livesey; M J Evans; L Mattioli; J Macdonald; A H Smith
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

7.  Recovery of hypothalamic-pituitary-adrenal function after intermittent high-dose prednisolone and cytotoxic chemotherapy.

Authors:  K S Wilson; C E Gray; G P Lidgard; A C Parker
Journal:  Postgrad Med J       Date:  1977-12       Impact factor: 2.401

8.  Acute adrenal insufficiency due to isolated corticotrophin deficiency.

Authors:  R J Corrall; G W Stewart; J G Ratcliffe
Journal:  J R Soc Med       Date:  1979-07       Impact factor: 18.000

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.